Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol

Details for Australian Patent Application No. 2002364238 (hide)

Owner MGI GP, Inc.

Inventors Williamson, Jeffrey A; Rhodes, Christopher A; Rogers, Tracey L

Agent Davies Collison Cave

Pub. Number AU-B-2002364238

PCT Number PCT/US02/41468

PCT Pub. Number WO2003/057153

Priority 60/342,755 28.12.01 US

Filing date 26 December 2002

Wipo publication date 24 July 2003

Acceptance publication date 18 January 2007

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/05 (2006.01)

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/16 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing nitrogen

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/20 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing sulfur

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61P 23/00 (2006.01) Anaesthetics

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/342,755 28.12.01 US

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2002364238

19 January 2006 Assignment before Grant

  Guilford Pharmaceuticals Inc. The application has been assigned to MGI GP, Inc. 2003

18 January 2007 Application Accepted

  Published as AU-B-2002364238

17 May 2007 Standard Patent Sealed

12 March 2009 Assignment Registered

  MGI GP, Inc. The patent has been assigned to Eisai Corporation of North America

1 October 2009 Assignment Registered

  Eisai Corporation of North America The patent has been assigned to Eisai Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002364239-METHOD USING A SURFACE-SELECTIVE NONLINEAR OPTICAL TECHNIQUE FOR IMAGING OF BIOLOGICAL SAMPLES

2002364237-COMPOSING AND CATALOGING ITEM CONFIGURATION DATA